Aspira Womens Health Analyst Ratings
Aspira Womens Health Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/26/2023 | -23.15% | Cantor Fitzgerald | → $4 | Reiterates | Neutral → Neutral |
| 08/22/2023 | 7.59% | Alliance Global Partners | → $5.6 | Initiates Coverage On | → Buy |
| 05/17/2023 | -13.54% | Cantor Fitzgerald | $2 → $4.5 | Maintains | Neutral |
| 01/20/2023 | -61.58% | Cantor Fitzgerald | $3 → $2 | Downgrades | Overweight → Neutral |
| 03/29/2021 | 130.55% | Truist Securities | → $12 | Initiates Coverage On | → Buy |
| 01/29/2021 | 92.12% | Cantor Fitzgerald | → $10 | Initiates Coverage On | → Overweight |
| 10/30/2020 | — | William Blair | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 09/26/2023 | -23.15% | 康托·菲茨杰拉德 | →$4 | 重申 | 中性→中性 |
| 2023年08月22日 | 7.59% | 联盟全球合作伙伴 | →$5.6 | 开始承保 | →购买 |
| 2023年05月17日 | -13.54% | 康托·菲茨杰拉德 | $2→$4.5 | 维护 | 中性 |
| 01/20/2023 | -61.58% | 康托·菲茨杰拉德 | $3→$2 | 评级下调 | 超重→中性 |
| 03/29/2021 | 130.55% | Truist证券 | →$12 | 开始承保 | →购买 |
| 2021/01/29 | 92.12% | 康托·菲茨杰拉德 | →$10 | 开始承保 | →超重 |
| 10/30/2020 | - | 威廉·布莱尔 | 开始承保 | →跑赢大盘 |
What is the target price for Aspira Womens Health (AWH)?
阿司匹拉女性健康(AWH)的目标价格是多少？
The latest price target for Aspira Womens Health (NASDAQ: AWH) was reported by Cantor Fitzgerald on September 26, 2023. The analyst firm set a price target for $4.00 expecting AWH to fall to within 12 months (a possible -23.15% downside). 4 analyst firms have reported ratings in the last year.
坎托·菲茨杰拉德于2023年9月26日报道了阿司匹拉妇女健康公司(纳斯达克：AWH)的最新目标价。这家分析公司将目标价定为4.00美元，预计AWH将在12个月内降至(可能下跌23.15%)。去年有4家分析公司公布了评级。
What is the most recent analyst rating for Aspira Womens Health (AWH)?
分析师对Aspira女性健康(AWH)的最新评级是多少？
The latest analyst rating for Aspira Womens Health (NASDAQ: AWH) was provided by Cantor Fitzgerald, and Aspira Womens Health reiterated their neutral rating.
分析师对阿司匹拉女性健康公司(纳斯达克代码：AWH)的最新评级是由坎托·菲茨杰拉德提供的，阿斯皮拉女性健康公司重申了他们的中性评级。
When is the next analyst rating going to be posted or updated for Aspira Womens Health (AWH)?
Aspira女性健康(AWH)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aspira Womens Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aspira Womens Health was filed on September 26, 2023 so you should expect the next rating to be made available sometime around September 26, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Aspira女性健康公司的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。对Aspira女性健康的上一次评级是在2023年9月26日提交的，所以你应该预计下一次评级将在2024年9月26日左右的某个时候提供。
Is the Analyst Rating Aspira Womens Health (AWH) correct?
分析师对Aspira女性健康(AWH)的评级正确吗？
While ratings are subjective and will change, the latest Aspira Womens Health (AWH) rating was a reiterated with a price target of $0.00 to $4.00. The current price Aspira Womens Health (AWH) is trading at is $5.21, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Aspira女性健康(AWH)评级被重申，目标价在0.00美元到4.00美元之间。目前阿司匹拉女性健康(AWH)的交易价格为5.21美元，超出了分析师的预测区间。